retatrutide eli lilly phase 2 results stock jumps on 3 weight loss Today, we shared new data

Users of similar drugs often struggle to maintain muscle mass, because their appetites are so reduced that taking in enough calories (and protein) becomes a challenge or tedious chore

Some novel GLP-1 RAs, such as PT302 and PT320, have data to show that they may reduce levodopa-induced dyskinesia and dopaminergic degeneration, suggesting a potential for synergistic therapy with levodopa

Week one success is measured by consistency, not results

GLP-1 receptor agonists This group of medicines is used for type 2 diabetes and overweight/obesity, alongside diet and exercise

Laurel Campbell, with West Tennessee Medical Group Primary Care & Pediatrics | Dyersburg, shares some insight below

8 GLP-1 is produced by L cells in the lower part of the small intestine and the colon